| 英文名称 | Wilfordine |
|---|---|
| 中文名称 | 雷公藤碱/雷公藤定碱 |
| CAS号 | 37239-51-3 |
| 分子式 | C43H49NO19 |
| 分子量 | 883.84 |
| 外观 | |
| 沸点 | 895.5±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 11.63±0.70 | Condition: Most Acidic Temp: 25 °C |
| 英文名称 | Wilfordine |
|---|---|
| 中文名称 | 雷公藤碱/雷公藤定碱 |
| CAS号 | 37239-51-3 |
| 分子式 | C43H49NO19 |
| 分子量 | 883.84 |
| 外观 | |
| 沸点 | 895.5±65.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 11.63±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0001414
中文名称：雷公藤碱
中文别名：雷公藤定碱
英文名称：Wilfordine
英文别名：Evonimine, 8-(acetyloxy)-O2-benzoyl-O2-deacetyl-8-deoxo-26-hydroxy-, (8α)-;Wilfordine (8CI);(8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,19,20-decahydro-18,21-dihydroxy-8,18,21-trimethyl-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17(18H)-dione;8,11-Epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17-dione, 10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-14-(benzoyloxy)-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-18,21-dihydroxy-8,18,21-trimethyl-, (8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-[partial]-;Wilfordin;Wtlfordine;
分子式：C43H49NO19
分子量：883.84
CAS号：37239-51-3
纯度：HPLC≥98%
沸点：895.5±65.0 °C | Condition: Press: 760 Torr
密度：1.44±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数：11.63±0.70 | Condition: Most Acidic Temp: 25 °C
储存条件：-20℃，干燥、避光、密封
规格：5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位：四川省维克奇生物科技有限公司
供应电话：028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，化学合成，抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等，敬请关注！ 新批次有现货，欢迎咨询。
| Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin-Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity. | ||
| 来源：SCI：Frontiers in Pharmacology | 作者：Wei Wu | 备注：影响因子：5.988 |
| 引用描述 | ||
TPL (Lot: 111,567–202,005) and irbesartan (as the IS for the MS/MS determination, Lot: 100,607–201,804) reference substances (content >99%) were obtained from National Institute for Food and Drug Control (Beijing, China). WA (Lot: wkq20040901), WFG (Lot: wkq20040804), WFT (Lot: wkq20040203), WFD (Lot: wkq20040702), and WFR (Lot: wkq20040205) reference substances (content >98%) were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Sichuan, China). Adriamycin (ADR) hydrochloride for injection (Lot: 2007E1) was provided by Shenzhen Main Luck Pharmaceuticals Inc. (Shenzhen, China). | ||
| Wilforine, the Q-marker and PK-maker of Tripterygium glycosides tablet: Based on preparation quantitative analysis and PK-PD study | ||
| 来源：SCI：PHYTOMEDICINE | 作者：Xue Gao | 备注：影响因子：3.61 |
| 引用描述 | ||
Wilfortrine (NO. 151128), wilforine (NO. 151218), wilforgine (NO. 150922), and wilfordine (NO. 160127) reference substances (purity > 98%) were all purchased from Sichuan Weikeqi Biological Technology Co., Ltd., tripterygium glycosides tablet samples were purchased from local pharmaceutical stores (Tianjin, China), which were produced by four manufactures (De-en De (DND) | ||
